{"url_path":"/sec/erna/8-k/2026-06-26/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-26","source_url":"https://www.sec.gov/Archives/edgar/data/748592/0001493152-26-030306-index.html","accession_number":"0001493152-26-030306","cik":"0000748592","ticker":"ERNA","issuer_name":"Ernexa Therapeutics Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/748592/0001493152-26-030306-index.html","primary_entity_key":"0000748592","primary_entity_name":"Ernexa Therapeutics Inc."},"word_count":74,"has_tables":true,"body_markdown":"**Item 9.01**\n**Financial Statements and Exhibits.**\n\n** **\n\n**(d)\nExhibits.**\n\n** **\n\n**Exhibit**\n\n**Number**\n\n \n**Description**\n\n104\n \nCover Page Interactive Data File (embedded within the\nInline XBRL document)\n\n \n\n-2-\n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by\nthe undersigned, hereunto duly authorized.\n\n \n\n \nErnexa Therapeutics Inc.\n\n \n \n \n\nDated: June 26, 2026\nBy:\n*/s/ Sanjeev Luther*\n\n \n \nSanjeev Luther\n\n \n \nPresident and Chief Executive Officer\n\n \n\n-3-"}